Last Updated : October 10, 2018
Details
FilesGeneric Name:
Tesamorelin
Project Status:
Complete
Therapeutic Area:
Lipodystrophy, HIV-infected patients
Manufacturer:
Theratechnologies Inc.
Call for patient/clinician input open:
Brand Name:
Egrifta
Project Line:
Reimbursement Review
Project Number:
SR0477-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Lipodystrophy, HIV-infected patients
Recommendation Type:
Do not reimburse
Final Recommendation:
Files
Last Updated : October 10, 2018